Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
CNS & Neurological Disorders Drug Targets|August 5, 2008
Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategiesRao Muralikrishna Adibhatla, James F Hatcher
Neurochemical Research|November 22, 2011
Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literatureRao Muralikrishna Adibhatla, J F Hatcher, A Gusain
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
Integration of cytokine biology and lipid metabolism in strokeRao Muralikrishna Adibhatla, Robert Dempsy, James Franklin Hatcher
Brain Research|September 13, 2005
CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in strokeRao Muralikrishna Adibhatla, J F Hatcher, K Tureyen
Antioxidants & Redox Signaling|October 29, 2003
Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemiaRao Muralikrishna Adibhatla, James F Hatcher, Robert J Dempsey
The AAPS Journal|June 27, 2006
Lipids and lipidomics in brain injury and diseasesRao Muralikrishna Adibhatla, J F Hatcher, R J Dempsey
Journal of Neurochemistry|January 18, 2002
Citicoline: neuroprotective mechanisms in cerebral ischemiaRao Muralikrishna Adibhatla, J F Hatcher, R J Dempsey
Journal of Neuroscience Research|April 14, 2004
Cytidine-5'-diphosphocholine affects CTP-phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemiaRao Muralikrishna Adibhatla, James F Hatcher, Robert J Dempsey
Molecular Neurobiology|March 15, 2012
Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibitionAnchal Gusain, James F Hatcher, Rao Muralikrishna Adibhatla, et al.
Pageof 3